Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial

By News Health
48 minutes Ago

(MedPage Today) — SAN FRANCISCO — For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement (TMVR).
Following the…

Source link : https://www.medpagetoday.com/meetingcoverage/tct/118208

Author :

Publish date : 2025-10-29 16:42:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Trump Team Targets State Laws Shielding Consumers' Credit Scores From Medical Debt

ACIP Staff Fired; Medical Freedom's Base Camp; Humiliating the CDC

New Evidence Ties Dementia Risk to Brain's Waste Clearance System

Study Identifies U.S. Regions Vulnerable to Trump's $100K Visas for Foreign Docs

SOFA Score Revision Released for Organ Dysfunction in Critical Illness

JAK Inhibitor Treatment Shows No Impact on Height in Kids